Skip to content
RNAWiki
Checking…
All public datasets

Public dataset

Recorded source agreement and disagreement

Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.

What this does not mean: agree can mean only that sources print the same normalized reading; it is not clinical-context equivalence, independent replication, or proof. differ requires matching structured context and disjoint comparable values. not_comparable and insufficient_context are not disagreement.
Public rows
1,681
Generated
Schema version
source-consensus/2

Coverage

What this run contains

Compared medicine fields
1,681
Agree
1,282
Differ
0
Not comparable
12
Insufficient context
387
Fields represented
5
bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution

Method

How the rows were made

  1. Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
  2. One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
  3. Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
  4. not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
  5. The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
  6. Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
  7. documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.

Limits

Read these before using a row

  • Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
  • The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
  • Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
  • Only the recorded fields and source documents in this snapshot are compared.
  • A source count is the number of retained source records in the row, not a count of independent experiments.

Provenance

Source examples

abacavir · bioavailability · agree

15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)
The geometric mean absolute bioavailability of the tablet was 83%.

alemtuzumab · volumeOfDistribution · not_comparable

2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)
Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).

abiraterone · halfLife · insufficient_context

31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)
Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.

Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.

Schema

Fields in the public projection

FieldTypeMeaning
medicineSlugstringStable RNAWiki medicine route key.
fieldstringRecorded pharmacokinetic field being compared.
comparisonStatestringagree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero.
comparisonReasonsstring[]Deterministic codes explaining the state.
documentsExaminednumberRecorded source documents considered for the field.
sourceCountnumberRecorded source readings represented.
agreementRatenumberShare represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability.
readingsconsensus-reading[]Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt.

Reader

Search and filter the rows

Case-insensitive text search over the public fields named for this dataset.

Exact comparability state.

Exact recorded field key.

Clear

Showing 581–590 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.

  1. Projected row 581

    Medicine slug
    famciclovir
    Compared field
    volumeOfDistribution
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    12
    Source count
    12
    Agreement rate
    1
    Recorded readings

    1. 1.08±0.17 L/kg

      Numeric value
      1.08
      Unit
      L/kg
      Source records
      12

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 12 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c2b21ad5-fa83-1fb6-e053-2a95a90a3d0f (opens source in a new tab)

        Famciclovir label

        Version not recorded · Effective date not recorded

        Distribution : The volume of distribution (Vdβ) was 1.08±0.17 L/kg in 12 healthy male subjects following a single intravenous dose of penciclovir at 400 mg administered as a 1-hour intravenous infusion.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c44b8d2-3b70-4e8b-af03-2e917178f761 (opens source in a new tab)

        Famciclovir label

        Version not recorded · Effective date not recorded

        Distribution : The volume of distribution (Vdβ) was 1.08±0.17 L/kg in 12 healthy male subjects following a single intravenous dose of penciclovir at 400 mg administered as a 1-hour intravenous infusion.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5723f50e-b0fa-65f0-e063-6294a90a350f (opens source in a new tab)

        Famciclovir label

        Version not recorded · Effective date not recorded

        Distribution : The volume of distribution (Vdβ) was 1.08 ± 0.17 L/kg in 12 healthy male subjects following a single intravenous dose of penciclovir at 400 mg administered as a 1-hour intravenous infusion.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:29b7ea8b-b976-45cb-9006-a27ba797b0fd (opens source in a new tab)

        Famciclovir label

        Version not recorded · Effective date not recorded

        Distribution : The volume of distribution (Vdβ) was 1.08 ± 0.17 L/kg in 12 healthy male subjects following a single intravenous dose of penciclovir at 400 mg administered as a 1-hour intravenous infusion.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d5c46506-a350-44a1-9440-d939da895f16 (opens source in a new tab)

        Famciclovir label

        Version not recorded · Effective date not recorded

        Distribution: The volume of distribution (Vdβ) was 1.08±0.17 L/kg in 12 healthy male subjects following a single intravenous dose of penciclovir at 400 mg administered as a 1-hour intravenous infusion.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c579bc7-8130-4935-a999-62b4b1c20706 (opens source in a new tab)

        Famciclovir label

        Version not recorded · Effective date not recorded

        Distribution : The volume of distribution (Vdβ) was 1.08 ± 0.17 L/kg in 12 healthy male subjects following a single intravenous dose of penciclovir at 400 mg administered as a 1-hour intravenous infusion.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d3faac3a-5c8c-4987-9703-c161fb29ec56 (opens source in a new tab)

        Famciclovir label

        Version not recorded · Effective date not recorded

        Distribution: The volume of distribution (Vdβ) was 1.08±0.17 L/kg in 12 healthy male subjects following a single intravenous dose of penciclovir at 400 mg administered as a 1-hour intravenous infusion.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eeeee9c4-8566-4100-8ca4-3df936a3365d (opens source in a new tab)

        Famciclovir label

        Version not recorded · Effective date not recorded

        Distribution: The volume of distribution (Vdβ) was 1.08±0.17 L/kg in 12 healthy male subjects following a single intravenous dose of penciclovir at 400 mg administered as a 1-hour intravenous infusion.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b75abffb-0a90-4abd-8ed8-81be1d8fe364 (opens source in a new tab)

        Famciclovir label

        Version not recorded · Effective date not recorded

        Distribution: The volume of distribution (Vdβ) was 1.08±0.17 L/kg in 12 healthy male subjects following a single intravenous dose of penciclovir at 400 mg administered as a 1-hour intravenous infusion.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3f02042f-8f51-4ccf-b608-5dcd75d100fb (opens source in a new tab)

        Famciclovir label

        Version not recorded · Effective date not recorded

        Distribution : The volume of distribution (Vdβ) was 1.08±0.17 L/kg in 12 healthy male subjects following a single intravenous dose of penciclovir at 400 mg administered as a 1-hour intravenous infusion.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:08c58224-5920-4853-8c59-ec5fbb66c2f6 (opens source in a new tab)

        Famciclovir label

        Version not recorded · Effective date not recorded

        Distribution : The volume of distribution (Vdβ) was 1.08 ± 0.17 L/kg in 12 healthy male subjects following a single intravenous dose of penciclovir at 400 mg administered as a 1-hour intravenous infusion.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fcf0b0fa-bb2c-4f2c-aa9f-1f2da65d8343 (opens source in a new tab)

        Famciclovir label

        Version not recorded · Effective date not recorded

        Distribution: The volume of distribution (Vdβ) was 1.08±0.17 L/kg in 12 healthy male subjects following a single intravenous dose of penciclovir at 400 mg administered as a 1-hour intravenous infusion.

  2. Projected row 582

    Medicine slug
    famotidine
    Compared field
    bioavailability
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    292
    Source count
    152
    Agreement rate
    0.927632
    Recorded readings

    1. 40 to 45%

      Numeric value
      40
      Unit
      %
      Source records
      141

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 141 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:900b4fd6-9c62-4b64-b4db-760c49ae0a42 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:66878006-8913-4c91-8038-901142cf520d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:354a5a02-45cb-4ab0-88ee-6635d5a43b01 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8e7f9c85-d165-47c7-8950-b22adcd6cece (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:88ac92eb-5684-46c8-8cd2-3d4aefee26cf (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0bdf4d1-8458-4e4f-95aa-bcc38c0f32f8 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4adb4864-04ac-4cb1-96c2-6196a30ac640 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a06502d9-7903-4f37-833e-e5763d502def (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ab235f4-da59-4a92-ad6b-c76cf3ecd985 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:69bd5340-298b-46ca-83c7-0b5ef233f9c5 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5648ca13-1add-56ec-e063-6294a90a6f29 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cd95271c-cf39-47fb-97a6-f6ee1e619e4a (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e53928f3-5181-490b-acfb-be8d4cea60a9 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8dbf43e0-856f-443b-b8a4-c69e006878ea (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4e803491-8030-50d0-e063-6294a90a5c8d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Orally administered famotidine is incompletely absorbed, and its bioavailability is 40 to 45%.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f149ecc1-d66c-42f9-a3f4-2ab6a522942b (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5ed77259-5dd9-4634-a073-346693488c4f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7e0da8be-b001-400e-99d1-37f335b1d7b3 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9948991d-9405-c7c8-e053-2995a90a60ca (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Orally administered famotidine is incompletely absorbed and its bioavailability is 40 to 45%.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:45df5fae-b28a-4b48-95ef-96e4faad883f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e3b13e23-122b-4bd4-95cf-b5a14b7afc05 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Orally administered famotidine is incompletely absorbed and its bioavailability is 40 to 45%.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7cef62ab-1740-4d0f-b6ea-fda783e1c197 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f5ec69d-926c-47a2-be47-8fef2e0ff207 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7b550cf9-221f-4f28-ba99-414ad7d5612f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dbf94314-3a34-4f03-80b1-296559b7d6a5 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74a24590-a0b6-4607-8e67-9fadce53389b (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31cdc900-fe17-2d5f-e063-6294a90a0fda (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97c33213-f415-4718-8466-9aa50371af70 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Orally administered famotidine is incompletely absorbed and its bioavailability is 40-45%.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:febe39b1-9212-a281-e053-6394a90a1a9f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c0e15f57-ab20-4030-b1d1-6aff33be7d76 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe21daca-ac48-4b46-9cb3-9a69af0c6a84 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0f34a3be-7554-4040-b808-5ba8bf064abc (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:06d286ce-14b3-4b66-8b42-ac4a10a0fc90 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:92048836-e692-4ce1-93f4-88b00acabcde (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:82930f64-4556-491f-96cc-270be9e3589a (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67a6e7f3-04d6-426c-b952-7677a84ace4d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:077bb160-e616-4863-bdde-989140f99e1c (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:70714491-1368-4824-98af-03fda52139a9 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c7327748-835b-44df-848f-8c620d327ce6 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:545d5c1f-ec1c-4135-965f-333ad888d96f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5995d726-f3f8-4c2d-af19-1b12e3f769c6 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Orally administered famotidine is incompletely absorbed, and its bioavailability is 40 to 45%.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d8cfa644-7cad-41b9-82a0-242a783fcbc8 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ce533636-cc9b-45d0-87a6-5390377ff28a (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Orally administered famotidine is incompletely absorbed, and its bioavailability is 40 to 45%.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0abfc8e6-7fdf-4828-89f4-2202002f8489 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8e41e259-b161-4f11-a6f7-14e6b60885b8 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b6214fc9-a274-ef45-e053-2a95a90ae43a (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Orally administered famotidine is incompletely absorbed and its bioavailability is 40 to 45%.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:273deac8-c2b0-423f-8662-4f16d91df216 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fa18ed52-f038-02dd-e053-6394a90ac946 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dfdca61d-8824-6230-e053-2995a90a209d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b0798337-1a73-415e-8416-613984ce5c65 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a24e8f45-6ace-4a81-8005-c23a55dadd9a (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b2228be0-472b-4e47-9910-af0bf12fde77 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4c6f4f9e-f3f5-4ecf-9f40-887e037e8847 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b1edf3c5-e42c-471b-8771-6c93094822de (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bbeffa0a-2bc7-fea4-e053-2a95a90ac511 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Orally administered famotidine is incompletely absorbed and its bioavailability is 40-45%.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:15b87f7f-1abf-4d8a-bdbe-03bea0021a68 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3549386a-533d-4e44-8097-f6bc51ee494a (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:11ce2a78-76ce-44df-afe3-57493498e596 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:702dd4fa-4a78-454d-91c5-493894750f7b (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e034546b-28cb-41aa-9441-655cdb966554 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:09ef39a4-c6b3-4395-8211-3f551dc44830 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:002875d2-8c30-2d2e-e063-6294a90ae01e (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43454e0f-4e1e-bbc6-e063-6394a90a5ac4 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74a69baa-a7c5-4e67-8db6-2ec39ab6cfe5 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2caaf94b-b382-4573-8614-57815776b659 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d515c2a-dac9-42d8-aede-66d28a427dbc (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e59a2c97-19c7-485c-bb1b-272ddb9ae053 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:44f3f63d-4522-91e4-e063-6394a90a6d1b (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9baf2596-b771-4bae-a03c-d3af6716821d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a8010e10-68fd-455f-968f-d62a1c3e0ffd (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8c7ca3cc-ff90-42a7-9218-554cf15348a3 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:13168d9e-0697-e5fb-e063-6294a90a69ba (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2bde8e1d-078f-4ba1-9ccb-29de6e36d8c4 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c4fe4e4-9ef2-4bc9-9016-e30ed9a5c958 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Orally administered famotidine is incompletely absorbed, and its bioavailability is 40 to 45%.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a3b50576-cd40-4f7e-9506-bd0a61988424 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:66f0bf15-ff35-426a-b40c-0d0da79d0861 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c133a9e1-ca48-4ee2-8768-01f44f5dd511 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9c5dce17-1865-4aa6-89f6-24dd55b5f06c (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0558e97-3bc3-4a1e-9248-1959b0344023 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db3af7cc-efc6-4934-acff-8bb2d31fe829 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cf2cd30e-9a0f-4b63-975c-5b551691cda9 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      82. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:68d21d95-9603-4e68-855a-bfc65b1b58c3 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      83. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ea50552f-f9b9-467f-a925-62ff027df607 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      84. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6edbd842-cf86-48a5-bc22-967620a2b5cb (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      85. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f32d0929-de22-4bec-9e24-bb549cf2679f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      86. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aeb27cea-1ff7-4a6e-93f1-d4c4dac5faa7 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Orally administered famotidine is incompletely absorbed, and its bioavailability is 40 to 45%.
      87. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:902b5d4b-1707-4312-9f46-ef5ab86b00f0 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      88. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:669fbd46-cae5-4477-884e-8eca893d2e05 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      89. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e6d167f-91e4-4122-911d-d3da66386f44 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      90. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5798d282-ce83-49aa-bc33-13203f2b5285 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      91. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2b6da72-72ea-d81b-e053-2995a90a9526 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      92. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7c0f3fa5-0a44-4a98-bc43-8bff8e95c462 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      93. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cdd5dfb7-4efb-4235-8023-5ce145c09038 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      94. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:32fd4101-15cb-411e-8b9d-270ec0592c6e (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      95. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54d93bf1-8f9a-981b-e063-6394a90a0fde (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      96. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cc88fbdc-546e-332f-e053-2995a90a8ca7 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      97. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:37361ccf-e080-d58e-e063-6394a90ab92e (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      98. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:60cd0973-f74e-2b70-e053-2a91aa0a4361 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40-45%.
      99. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c84b0ba3-1ba8-4da9-b5b8-186e01cda999 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40-45%.
      100. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b556d1a8-4155-50cf-e053-2995a90a9b14 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      101. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3031c7d1-5a4e-42b3-a3ca-9ac2ea2f76fb (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      102. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a583080-6771-4246-a221-2491e9e5d8af (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      103. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2cdd1a75-5d68-7f9d-e063-6294a90aeee3 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      104. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fc603d56-6828-8c5e-e053-6394a90a35bd (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      105. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c72fad2e-3ffb-4f83-e053-2a95a90a3f9c (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      106. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be69d9f9-f4ad-4cfe-bab2-e07186b25c1e (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      107. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3c32f8e2-f54a-422d-9c25-68692ea09001 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      108. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d60bde93-f512-4071-9e4b-1d8318def3bc (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      109. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b445a613-eaa8-45e8-be1f-5848bfd1dd36 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      110. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4421ceb7-a114-436c-871a-7bc5444f8154 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      111. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eec89230-47fc-4139-a370-b4f9e225e8c0 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      112. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:05b47b1d-f7f3-4dae-9b22-d43d2a7cfaef (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      113. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:92a75aa6-3c63-4c98-be8e-dcd03affc10b (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      114. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:99de67a5-a566-46c9-bc80-dc6fc03be11f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      115. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:75a334ee-48b9-47e7-8225-6e595bed8a74 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      116. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:138d9ed1-2f8f-d19d-e063-6394a90a695d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      117. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b1839d23-20f4-4651-a7d2-8bc3a7583917 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      118. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4b820924-24ad-4a2f-e054-00144ff88e88 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      119. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f67bcbc7-952c-61c0-e053-2a95a90a6fa6 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      120. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1fdf16e5-145d-4c19-a318-fc6c10794b50 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Orally administered famotidine is incompletely absorbed, and its bioavailability is 40 to 45%.
      121. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:18066b80-1ec6-4092-80d9-70adb0ecac85 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      122. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ab1cdbbf-d838-020c-e053-2995a90a0f65 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      123. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55730918-d9e8-eaad-e063-6394a90aeda2 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      124. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0f38398-4d34-4ecc-8a6a-37732adaaad3 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      125. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:599642c8-51cd-4220-e063-6394a90a5e20 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      126. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fd5d15b9-b1b5-48ef-ba41-8a43a7642e94 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      127. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b1b82d2a-cdb5-3e22-e053-2995a90a917d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      128. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a8b5c855-053d-4295-8f57-1a96a6ccaa92 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      129. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:044a510f-33df-4484-8f07-d821f52b9376 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      130. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04aaf296-f136-29d7-e063-6294a90affe1 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      131. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1e2003d4-09a3-4cc8-af3d-93d29b9123c0 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      132. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74ff64f2-d882-411f-bac8-29dfa4cb4f10 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      133. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ea7287a4-75e0-39d2-5b2e-b72b7cb386b9 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      134. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:46c6d243-eefc-40ca-8bd4-4c89456f635f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      135. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fd271deb-c748-bf26-e053-6294a90a11aa (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      136. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:81f24752-3474-3013-0013-5570c8e7baf7 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      137. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:59b17677-d805-4d9e-9c64-96385ae47bff (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      138. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1756ab7d-05c4-4726-8f72-4e8363440968 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      139. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:21953598-e7ec-45c2-8fca-05550a1ddf38 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      140. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ae3646c7-76fc-473d-b20b-67d3c6ac0b75 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.
      141. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:03503cd5-bd8e-4bff-b90d-1a71c5225b91 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40 to 45%.

    2. 40%

      Numeric value
      40
      Unit
      %
      Source records
      11

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 11 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8dc075fe-a3e5-4710-8c19-73558a8c5f09 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40% to 45%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d528fadf-316f-4fea-9bec-070c01f80d64 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40% to 45%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:72a97532-9a79-4cbf-b9d0-22ce1f21468d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40% to 45%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b5cb132-d28f-4fbe-91f5-dc04f9a551d1 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40% to 45%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0786d7f5-85a7-d835-e063-6394a90ad719 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40% to 45%.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:443e8ea6-7d51-4db7-8f0b-7a854d45bf23 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40% to 45%.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a88e7069-230c-4105-ade0-a98968e18671 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40% to 45%.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bb602b05-0ce6-4029-bd6e-291076e64efb (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40% to 45%.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b165979b-7ed0-423e-9aeb-2e061df0cd45 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40% to 45%.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c013654e-9cad-4c59-8fea-b00ae1567c18 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40% to 45%.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f175822d-7ca4-fa33-e053-2995a90ac310 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        The bioavailability of oral doses is 40% to 45%.

  3. Projected row 583

    Medicine slug
    famotidine
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    292
    Source count
    153
    Agreement rate
    0.954248
    Recorded readings

    1. 2.5 to 3.5 hours

      Numeric value
      2.5
      Unit
      hours
      Source records
      146

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 146 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:900b4fd6-9c62-4b64-b4db-760c49ae0a42 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion: Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:66878006-8913-4c91-8038-901142cf520d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:354a5a02-45cb-4ab0-88ee-6635d5a43b01 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8e7f9c85-d165-47c7-8950-b22adcd6cece (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:88ac92eb-5684-46c8-8cd2-3d4aefee26cf (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0bdf4d1-8458-4e4f-95aa-bcc38c0f32f8 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4adb4864-04ac-4cb1-96c2-6196a30ac640 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d528fadf-316f-4fea-9bec-070c01f80d64 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a06502d9-7903-4f37-833e-e5763d502def (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ab235f4-da59-4a92-ad6b-c76cf3ecd985 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:69bd5340-298b-46ca-83c7-0b5ef233f9c5 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5648ca13-1add-56ec-e063-6294a90a6f29 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cd95271c-cf39-47fb-97a6-f6ee1e619e4a (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e53928f3-5181-490b-acfb-be8d4cea60a9 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8dbf43e0-856f-443b-b8a4-c69e006878ea (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4e803491-8030-50d0-e063-6294a90a5c8d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f149ecc1-d66c-42f9-a3f4-2ab6a522942b (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5ed77259-5dd9-4634-a073-346693488c4f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7e0da8be-b001-400e-99d1-37f335b1d7b3 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9948991d-9405-c7c8-e053-2995a90a60ca (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:45df5fae-b28a-4b48-95ef-96e4faad883f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion: Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e3b13e23-122b-4bd4-95cf-b5a14b7afc05 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7cef62ab-1740-4d0f-b6ea-fda783e1c197 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f5ec69d-926c-47a2-be47-8fef2e0ff207 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7b550cf9-221f-4f28-ba99-414ad7d5612f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dbf94314-3a34-4f03-80b1-296559b7d6a5 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74a24590-a0b6-4607-8e67-9fadce53389b (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31cdc900-fe17-2d5f-e063-6294a90a0fda (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97c33213-f415-4718-8466-9aa50371af70 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5-3.5 hours.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:febe39b1-9212-a281-e053-6394a90a1a9f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c0e15f57-ab20-4030-b1d1-6aff33be7d76 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe21daca-ac48-4b46-9cb3-9a69af0c6a84 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0f34a3be-7554-4040-b808-5ba8bf064abc (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:06d286ce-14b3-4b66-8b42-ac4a10a0fc90 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:92048836-e692-4ce1-93f4-88b00acabcde (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:82930f64-4556-491f-96cc-270be9e3589a (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67a6e7f3-04d6-426c-b952-7677a84ace4d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:077bb160-e616-4863-bdde-989140f99e1c (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:70714491-1368-4824-98af-03fda52139a9 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c7327748-835b-44df-848f-8c620d327ce6 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:545d5c1f-ec1c-4135-965f-333ad888d96f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5995d726-f3f8-4c2d-af19-1b12e3f769c6 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d8cfa644-7cad-41b9-82a0-242a783fcbc8 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ce533636-cc9b-45d0-87a6-5390377ff28a (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0abfc8e6-7fdf-4828-89f4-2202002f8489 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8e41e259-b161-4f11-a6f7-14e6b60885b8 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion: Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b6214fc9-a274-ef45-e053-2a95a90ae43a (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:273deac8-c2b0-423f-8662-4f16d91df216 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fa18ed52-f038-02dd-e053-6394a90ac946 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dfdca61d-8824-6230-e053-2995a90a209d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b0798337-1a73-415e-8416-613984ce5c65 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a24e8f45-6ace-4a81-8005-c23a55dadd9a (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b2228be0-472b-4e47-9910-af0bf12fde77 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4c6f4f9e-f3f5-4ecf-9f40-887e037e8847 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b1edf3c5-e42c-471b-8771-6c93094822de (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:443e8ea6-7d51-4db7-8f0b-7a854d45bf23 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bbeffa0a-2bc7-fea4-e053-2a95a90ac511 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5-3.5 hours.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:15b87f7f-1abf-4d8a-bdbe-03bea0021a68 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3549386a-533d-4e44-8097-f6bc51ee494a (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:11ce2a78-76ce-44df-afe3-57493498e596 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:702dd4fa-4a78-454d-91c5-493894750f7b (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e034546b-28cb-41aa-9441-655cdb966554 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:09ef39a4-c6b3-4395-8211-3f551dc44830 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:002875d2-8c30-2d2e-e063-6294a90ae01e (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43454e0f-4e1e-bbc6-e063-6394a90a5ac4 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74a69baa-a7c5-4e67-8db6-2ec39ab6cfe5 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2caaf94b-b382-4573-8614-57815776b659 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion: Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d515c2a-dac9-42d8-aede-66d28a427dbc (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e59a2c97-19c7-485c-bb1b-272ddb9ae053 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:44f3f63d-4522-91e4-e063-6394a90a6d1b (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bb602b05-0ce6-4029-bd6e-291076e64efb (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9baf2596-b771-4bae-a03c-d3af6716821d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a8010e10-68fd-455f-968f-d62a1c3e0ffd (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8c7ca3cc-ff90-42a7-9218-554cf15348a3 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:13168d9e-0697-e5fb-e063-6294a90a69ba (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2bde8e1d-078f-4ba1-9ccb-29de6e36d8c4 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c4fe4e4-9ef2-4bc9-9016-e30ed9a5c958 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a3b50576-cd40-4f7e-9506-bd0a61988424 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:66f0bf15-ff35-426a-b40c-0d0da79d0861 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c133a9e1-ca48-4ee2-8768-01f44f5dd511 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9c5dce17-1865-4aa6-89f6-24dd55b5f06c (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      82. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0558e97-3bc3-4a1e-9248-1959b0344023 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      83. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db3af7cc-efc6-4934-acff-8bb2d31fe829 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      84. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cf2cd30e-9a0f-4b63-975c-5b551691cda9 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      85. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:68d21d95-9603-4e68-855a-bfc65b1b58c3 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      86. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ea50552f-f9b9-467f-a925-62ff027df607 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      87. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6edbd842-cf86-48a5-bc22-967620a2b5cb (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      88. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f32d0929-de22-4bec-9e24-bb549cf2679f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      89. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aeb27cea-1ff7-4a6e-93f1-d4c4dac5faa7 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      90. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:902b5d4b-1707-4312-9f46-ef5ab86b00f0 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      91. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:669fbd46-cae5-4477-884e-8eca893d2e05 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      92. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e6d167f-91e4-4122-911d-d3da66386f44 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      93. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5798d282-ce83-49aa-bc33-13203f2b5285 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      94. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2b6da72-72ea-d81b-e053-2995a90a9526 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      95. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7c0f3fa5-0a44-4a98-bc43-8bff8e95c462 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      96. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cdd5dfb7-4efb-4235-8023-5ce145c09038 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      97. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:32fd4101-15cb-411e-8b9d-270ec0592c6e (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      98. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54d93bf1-8f9a-981b-e063-6394a90a0fde (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      99. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cc88fbdc-546e-332f-e053-2995a90a8ca7 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      100. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:37361ccf-e080-d58e-e063-6394a90ab92e (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      101. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:60cd0973-f74e-2b70-e053-2a91aa0a4361 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5-3.5 hours.
      102. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c84b0ba3-1ba8-4da9-b5b8-186e01cda999 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5-3.5 hours.
      103. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b556d1a8-4155-50cf-e053-2995a90a9b14 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      104. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3031c7d1-5a4e-42b3-a3ca-9ac2ea2f76fb (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      105. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a583080-6771-4246-a221-2491e9e5d8af (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      106. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2cdd1a75-5d68-7f9d-e063-6294a90aeee3 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      107. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fc603d56-6828-8c5e-e053-6394a90a35bd (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      108. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c72fad2e-3ffb-4f83-e053-2a95a90a3f9c (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion: Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      109. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be69d9f9-f4ad-4cfe-bab2-e07186b25c1e (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      110. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3c32f8e2-f54a-422d-9c25-68692ea09001 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      111. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d60bde93-f512-4071-9e4b-1d8318def3bc (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      112. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b445a613-eaa8-45e8-be1f-5848bfd1dd36 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      113. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9710995d-b518-40ce-bc2b-8b5dcf002c31 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      114. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4421ceb7-a114-436c-871a-7bc5444f8154 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      115. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eec89230-47fc-4139-a370-b4f9e225e8c0 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      116. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:05b47b1d-f7f3-4dae-9b22-d43d2a7cfaef (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      117. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:92a75aa6-3c63-4c98-be8e-dcd03affc10b (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      118. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:99de67a5-a566-46c9-bc80-dc6fc03be11f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      119. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:75a334ee-48b9-47e7-8225-6e595bed8a74 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      120. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:138d9ed1-2f8f-d19d-e063-6394a90a695d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      121. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b1839d23-20f4-4651-a7d2-8bc3a7583917 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      122. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4b820924-24ad-4a2f-e054-00144ff88e88 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      123. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f67bcbc7-952c-61c0-e053-2a95a90a6fa6 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      124. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1fdf16e5-145d-4c19-a318-fc6c10794b50 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      125. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:18066b80-1ec6-4092-80d9-70adb0ecac85 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      126. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ab1cdbbf-d838-020c-e053-2995a90a0f65 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      127. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55730918-d9e8-eaad-e063-6394a90aeda2 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      128. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0f38398-4d34-4ecc-8a6a-37732adaaad3 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      129. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c013654e-9cad-4c59-8fea-b00ae1567c18 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      130. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:599642c8-51cd-4220-e063-6394a90a5e20 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      131. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fd5d15b9-b1b5-48ef-ba41-8a43a7642e94 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      132. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b1b82d2a-cdb5-3e22-e053-2995a90a917d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      133. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a8b5c855-053d-4295-8f57-1a96a6ccaa92 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      134. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:044a510f-33df-4484-8f07-d821f52b9376 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      135. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04aaf296-f136-29d7-e063-6294a90affe1 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion: Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      136. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1e2003d4-09a3-4cc8-af3d-93d29b9123c0 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      137. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74ff64f2-d882-411f-bac8-29dfa4cb4f10 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      138. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ea7287a4-75e0-39d2-5b2e-b72b7cb386b9 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion: Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      139. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:46c6d243-eefc-40ca-8bd4-4c89456f635f (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      140. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fd271deb-c748-bf26-e053-6294a90a11aa (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      141. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:81f24752-3474-3013-0013-5570c8e7baf7 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      142. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:59b17677-d805-4d9e-9c64-96385ae47bff (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      143. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1756ab7d-05c4-4726-8f72-4e8363440968 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      144. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:21953598-e7ec-45c2-8fca-05550a1ddf38 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.
      145. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ae3646c7-76fc-473d-b20b-67d3c6ac0b75 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5-3.5 hours.
      146. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:03503cd5-bd8e-4bff-b90d-1a71c5225b91 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 to 3.5 hours.

    2. 2.5 hours

      Numeric value
      2.5
      Unit
      hours
      Source records
      7

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 7 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8dc075fe-a3e5-4710-8c19-73558a8c5f09 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 hours to 3.5 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:72a97532-9a79-4cbf-b9d0-22ce1f21468d (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 hours to 3.5 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b5cb132-d28f-4fbe-91f5-dc04f9a551d1 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 hours to 3.5 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0786d7f5-85a7-d835-e063-6394a90ad719 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 hours to 3.5 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a88e7069-230c-4105-ade0-a98968e18671 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 hours to 3.5 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b165979b-7ed0-423e-9aeb-2e061df0cd45 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 hours to 3.5 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f175822d-7ca4-fa33-e053-2995a90ac310 (opens source in a new tab)

        Famotidine label

        Version not recorded · Effective date not recorded

        Excretion Famotidine has an elimination half-life of 2.5 hours to 3.5 hours.

  4. Projected row 584

    Medicine slug
    febuxostat
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    25
    Source count
    25
    Agreement rate
    0.88
    Recorded readings

    1. 5 to 8 hours

      Numeric value
      5
      Unit
      hours
      Source records
      22

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 22 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ad40e0f6-850c-429a-87fc-f1eb2361e962 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t ½ ) of approximately 5 to 8 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d1969ea8-5178-42ee-97fc-feee8595e677 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:14f1555c-2565-42c7-b3f5-dd5f03fed67a (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ccf2c4b1-e9a3-c7b7-ac42-79e1988fc211 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:13a80059-46f7-4453-ab37-72744657a08a (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a745be75-4fa5-cbf9-e053-2995a90a3a81 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4f5f8f2b-7200-4d76-9049-11dbc6cbd2ca (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d3b18653-9487-4a78-82c0-80ee024b8ef6 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:73b07a94-c044-42dc-abe4-7d7c860c9638 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54de10ef-fe5f-4930-b91d-6bbb04c664bd (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04f80eb2-8171-4e18-93e4-514440e84b75 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:14f80ad5-37cc-4672-9caa-2dd2f469af0a (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t ½ ) of approximately 5 to 8 hours.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1f7541bd-bf32-422b-b99a-89193cf193ca (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t ½ ) of approximately 5 to 8 hours.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bf4d29c8-4731-42bc-887a-d8302add9ca9 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97a8c7fc-0a66-2ddc-e053-2a95a90ad313 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:164feabd-f722-445b-b81a-d975b3db5f53 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41a95424-046e-413b-a121-cd7335e67135 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life ( t1/2 ) of approximately 5 to 8 hours.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bc986925-fd24-4865-997c-ede55c2faffc (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9a87099f-d82d-42c7-872a-b87d3917e960 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life ( t1/2 ) of approximately 5 to 8 hours.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:154ad94e-b775-4a10-ab0f-2874a0782db9 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b5cf14a-6c5f-1eb2-e063-6294a90aaac8 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t ½ ) of approximately 5 to 8 hours.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4f1d0452-e041-cda6-e063-6394a90a2aef (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 to 8 hours.

    2. 5 hours

      Numeric value
      5
      Unit
      hours
      Source records
      3

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 3 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b2aeb900-d792-48b2-b678-94f82d68be32 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 hours to 8 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b5d205f-30e3-33e6-e063-6394a90aa683 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 hours to 8 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2c338dc-5bab-49f4-a4ac-d8dea8afeea5 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Febuxostat has an apparent mean terminal elimination half-life (t 1/2 ) of approximately 5 hours to 8 hours.

  5. Projected row 585

    Medicine slug
    febuxostat
    Compared field
    proteinBinding
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    25
    Source count
    25
    Agreement rate
    1
    Recorded readings

    1. 99.2%

      Numeric value
      99.2
      Unit
      %
      Source records
      25

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 25 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ad40e0f6-850c-429a-87fc-f1eb2361e962 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2%, (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d1969ea8-5178-42ee-97fc-feee8595e677 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2%, (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:14f1555c-2565-42c7-b3f5-dd5f03fed67a (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ccf2c4b1-e9a3-c7b7-ac42-79e1988fc211 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:13a80059-46f7-4453-ab37-72744657a08a (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2%, (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a745be75-4fa5-cbf9-e053-2995a90a3a81 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2%, (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4f5f8f2b-7200-4d76-9049-11dbc6cbd2ca (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d3b18653-9487-4a78-82c0-80ee024b8ef6 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:73b07a94-c044-42dc-abe4-7d7c860c9638 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54de10ef-fe5f-4930-b91d-6bbb04c664bd (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04f80eb2-8171-4e18-93e4-514440e84b75 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:14f80ad5-37cc-4672-9caa-2dd2f469af0a (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b2aeb900-d792-48b2-b678-94f82d68be32 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b5d205f-30e3-33e6-e063-6394a90aa683 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1f7541bd-bf32-422b-b99a-89193cf193ca (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bf4d29c8-4731-42bc-887a-d8302add9ca9 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2%, (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97a8c7fc-0a66-2ddc-e053-2a95a90ad313 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:164feabd-f722-445b-b81a-d975b3db5f53 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2%, (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41a95424-046e-413b-a121-cd7335e67135 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bc986925-fd24-4865-997c-ede55c2faffc (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9a87099f-d82d-42c7-872a-b87d3917e960 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:154ad94e-b775-4a10-ab0f-2874a0782db9 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b5cf14a-6c5f-1eb2-e063-6294a90aaac8 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2%, (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4f1d0452-e041-cda6-e063-6394a90a2aef (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2c338dc-5bab-49f4-a4ac-d8dea8afeea5 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        The plasma protein binding of febuxostat is approximately 99.2% (primarily to albumin), and is constant over the concentration range achieved with 40 mg and 80 mg doses.

  6. Projected row 586

    Medicine slug
    febuxostat
    Compared field
    volumeOfDistribution
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    25
    Source count
    25
    Agreement rate
    1
    Recorded readings

    1. 50 L

      Numeric value
      50
      Unit
      L
      Source records
      25

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 25 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ad40e0f6-850c-429a-87fc-f1eb2361e962 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d1969ea8-5178-42ee-97fc-feee8595e677 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:14f1555c-2565-42c7-b3f5-dd5f03fed67a (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution: The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ccf2c4b1-e9a3-c7b7-ac42-79e1988fc211 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:13a80059-46f7-4453-ab37-72744657a08a (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a745be75-4fa5-cbf9-e053-2995a90a3a81 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4f5f8f2b-7200-4d76-9049-11dbc6cbd2ca (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d3b18653-9487-4a78-82c0-80ee024b8ef6 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (Vss/F) of febuxostat was approximately 50 L (CV ~40%).
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:73b07a94-c044-42dc-abe4-7d7c860c9638 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54de10ef-fe5f-4930-b91d-6bbb04c664bd (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04f80eb2-8171-4e18-93e4-514440e84b75 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:14f80ad5-37cc-4672-9caa-2dd2f469af0a (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b2aeb900-d792-48b2-b678-94f82d68be32 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady-state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b5d205f-30e3-33e6-e063-6394a90aa683 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady-state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1f7541bd-bf32-422b-b99a-89193cf193ca (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bf4d29c8-4731-42bc-887a-d8302add9ca9 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97a8c7fc-0a66-2ddc-e053-2a95a90ad313 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution: The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:164feabd-f722-445b-b81a-d975b3db5f53 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41a95424-046e-413b-a121-cd7335e67135 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bc986925-fd24-4865-997c-ede55c2faffc (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution: The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9a87099f-d82d-42c7-872a-b87d3917e960 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:154ad94e-b775-4a10-ab0f-2874a0782db9 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (Vss/F) of febuxostat was approximately 50 L (CV ~40%).
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b5cf14a-6c5f-1eb2-e063-6294a90aaac8 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4f1d0452-e041-cda6-e063-6394a90a2aef (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2c338dc-5bab-49f4-a4ac-d8dea8afeea5 (opens source in a new tab)

        Febuxostat label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent steady-state volume of distribution (V ss /F) of febuxostat was approximately 50 L (CV ~40%).

  7. Projected row 587

    Medicine slug
    felbamate
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    14
    Source count
    14
    Agreement rate
    1
    Recorded readings

    1. 20-23 hours

      Numeric value
      20
      Unit
      hours
      Source records
      14

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 14 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f522701-397a-11de-8a39-0800200c9a66 (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20-23 hours, which is unaltered after multiple doses.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6afd77f2-4525-42f4-a4b1-94159c401dd2 (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20 to 23 hours, which is unaltered after multiple doses.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0afffb17-e6ac-4bea-a90e-7ef3c8150290 (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20 to 23 hours, which is unaltered after multiple doses.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2e325d79-d0a4-4af7-b09b-96ee5a5b2a37 (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20 to 23 hours, which is unaltered after multiple doses.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1aa40de5-c02d-49d6-8722-ed88c40c3ba6 (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20 to 23 hours, which is unaltered after multiple doses.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3170233c-0452-4150-9e4c-dfffcde7424e (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20 to 23 hours, which is unaltered after multiple doses.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:696e3cbb-a431-4f29-acbd-1db8e9aaef93 (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20 to 23 hours, which is unaltered after multiple doses.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:556de35d-3b98-48d3-a670-50e9d93437a4 (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20 to 23 hours, which is unaltered after multiple doses.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:81c8a2e1-732c-4467-84e9-53fef1655ee2 (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20-23 hours, which is unaltered after multiple doses.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aa3fd2c0-98d6-45f3-81b0-a902526214c6 (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20 to 23 hours, which is unaltered after multiple doses.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:17850520-f823-4d05-8f9b-5eadfa68bae2 (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20 to 23 hours, which is unaltered after multiple doses.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2edb3ed-da20-4093-88ea-00fe781e47e0 (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20 to 23 hours, which is unaltered after multiple doses.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d6eaf094-09e2-480c-bea9-7a2768aad884 (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20 to 23 hours, which is unaltered after multiple doses.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:96f4357c-720c-4651-b638-7b1181531dc5 (opens source in a new tab)

        Felbamate label

        Version not recorded · Effective date not recorded

        Felbamate is excreted with a terminal half-life of 20 to 23 hours, which is unaltered after multiple doses.

  8. Projected row 588

    Medicine slug
    felodipine
    Compared field
    bioavailability
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    29
    Source count
    29
    Agreement rate
    1
    Recorded readings

    1. 20%

      Numeric value
      20
      Unit
      %
      Source records
      29

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 29 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be3bc927-1ba5-4cdd-9986-64ff29789d7e (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7bd4fa00-f0d8-4aea-9c24-a799b05e60e1 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fddebfce-70ed-4ee1-8598-bbb8f1ca9263 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of Felodipine, is approximately 20%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:129c48eb-29f2-462b-ad8a-b3bf1b193115 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of Felodipine, is approximately 20%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c4dd9a4-61ca-4c88-90f6-12d9e0fdb7cd (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:063e633b-03ca-46e2-b6a0-8a300fccee93 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:782c981d-419a-4fe4-ba44-087731642c78 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:57fb4217-00f6-4112-bc63-81fcbe2ea903 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine is approximately 20%.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:45e3094c-7755-48c2-be65-c0377f18a400 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine is approximately 20%.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b27a13d4-c068-43c8-b654-b8b3276e468a (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine is approximately 20%.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:60fb803e-ccf7-46f2-b506-e157ce440f87 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine is approximately 20%.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:924b2633-74bd-469f-b831-77f09dfebbf7 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine is approximately 20%.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5c7b7f9a-4f4c-4259-8aae-fdb91ab09eec (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8eadbf3d-c93b-431c-aa86-559fc2a1d5a8 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2daac7f7-66a8-4be7-b7de-4f1e60bb21f9 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e83f5688-55fd-492c-b0d6-e1028d12d618 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine is approximately 20%.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f5f56c59-04d5-4c5d-9441-5a93d3bdec82 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55637724-8757-11de-8a39-0800200c9a66 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine is approximately 20%.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dd39c559-5c5d-4d3b-9228-c44085e1699f (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b410a9aa-2014-4c25-8a54-2987477650e3 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bdd41c3a-c537-02f3-e053-2995a90a8929 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6560584-e39f-47b3-84db-95da1f90fd40 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of Felodipine, is approximately 20%.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:196ef773-8a2a-4ef7-a403-2341f94f4d98 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine is approximately 20%.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:30d15f4b-a0ee-4841-ace3-dcaf52016953 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine is approximately 20%.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca1c3b54-15a1-4252-938a-0d90f3bec4c5 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2e4298cf-02e9-49c7-9803-887161e1989a (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine is approximately 20%.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:05feb0a1-8a0c-4d8a-9b86-5e700ea6fd64 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine is approximately 20%.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:78341a0a-1274-417e-ae69-e133ee0480f9 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine extended-release tablets is approximately 20%.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0bef7cf2-012b-4804-ac93-0a8b333035db (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic bioavailability of felodipine is approximately 20%.

  9. Projected row 589

    Medicine slug
    felodipine
    Compared field
    tMax
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    29
    Source count
    29
    Agreement rate
    1
    Recorded readings

    1. 2.5 to 5 hours

      Numeric value
      2.5
      Unit
      hours
      Source records
      29

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 29 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be3bc927-1ba5-4cdd-9986-64ff29789d7e (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7bd4fa00-f0d8-4aea-9c24-a799b05e60e1 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fddebfce-70ed-4ee1-8598-bbb8f1ca9263 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of Felodipine are reached in 2.5 to 5 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:129c48eb-29f2-462b-ad8a-b3bf1b193115 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of Felodipine are reached in 2.5 to 5 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c4dd9a4-61ca-4c88-90f6-12d9e0fdb7cd (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:063e633b-03ca-46e2-b6a0-8a300fccee93 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:782c981d-419a-4fe4-ba44-087731642c78 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:57fb4217-00f6-4112-bc63-81fcbe2ea903 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:45e3094c-7755-48c2-be65-c0377f18a400 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets, USP are reached in 2.5 to 5 hours.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b27a13d4-c068-43c8-b654-b8b3276e468a (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets, USP are reached in 2.5 to 5 hours.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:60fb803e-ccf7-46f2-b506-e157ce440f87 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:924b2633-74bd-469f-b831-77f09dfebbf7 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine are reached in 2.5 to 5 hours.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5c7b7f9a-4f4c-4259-8aae-fdb91ab09eec (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8eadbf3d-c93b-431c-aa86-559fc2a1d5a8 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2daac7f7-66a8-4be7-b7de-4f1e60bb21f9 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e83f5688-55fd-492c-b0d6-e1028d12d618 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f5f56c59-04d5-4c5d-9441-5a93d3bdec82 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55637724-8757-11de-8a39-0800200c9a66 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets, USP are reached in 2.5 to 5 hours.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dd39c559-5c5d-4d3b-9228-c44085e1699f (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b410a9aa-2014-4c25-8a54-2987477650e3 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bdd41c3a-c537-02f3-e053-2995a90a8929 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6560584-e39f-47b3-84db-95da1f90fd40 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of Felodipine are reached in 2.5 to 5 hours.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:196ef773-8a2a-4ef7-a403-2341f94f4d98 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets, USP are reached in 2.5 to 5 hours.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:30d15f4b-a0ee-4841-ace3-dcaf52016953 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets, USP are reached in 2.5 to 5 hours.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca1c3b54-15a1-4252-938a-0d90f3bec4c5 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2e4298cf-02e9-49c7-9803-887161e1989a (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine are reached in 2.5 to 5 hours.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:05feb0a1-8a0c-4d8a-9b86-5e700ea6fd64 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets, USP are reached in 2.5 to 5 hours.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:78341a0a-1274-417e-ae69-e133ee0480f9 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0bef7cf2-012b-4804-ac93-0a8b333035db (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        Mean peak concentrations following the administration of felodipine extended-release tablets are reached in 2.5 to 5 hours.

  10. Projected row 590

    Medicine slug
    felodipine
    Compared field
    volumeOfDistribution
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    29
    Source count
    29
    Agreement rate
    1
    Recorded readings

    1. 10 L/kg

      Numeric value
      10
      Unit
      L/kg
      Source records
      29

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 29 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be3bc927-1ba5-4cdd-9986-64ff29789d7e (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7bd4fa00-f0d8-4aea-9c24-a799b05e60e1 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fddebfce-70ed-4ee1-8598-bbb8f1ca9263 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:129c48eb-29f2-462b-ad8a-b3bf1b193115 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c4dd9a4-61ca-4c88-90f6-12d9e0fdb7cd (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:063e633b-03ca-46e2-b6a0-8a300fccee93 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:782c981d-419a-4fe4-ba44-087731642c78 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:57fb4217-00f6-4112-bc63-81fcbe2ea903 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:45e3094c-7755-48c2-be65-c0377f18a400 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b27a13d4-c068-43c8-b654-b8b3276e468a (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:60fb803e-ccf7-46f2-b506-e157ce440f87 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:924b2633-74bd-469f-b831-77f09dfebbf7 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5c7b7f9a-4f4c-4259-8aae-fdb91ab09eec (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8eadbf3d-c93b-431c-aa86-559fc2a1d5a8 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2daac7f7-66a8-4be7-b7de-4f1e60bb21f9 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e83f5688-55fd-492c-b0d6-e1028d12d618 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f5f56c59-04d5-4c5d-9441-5a93d3bdec82 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55637724-8757-11de-8a39-0800200c9a66 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dd39c559-5c5d-4d3b-9228-c44085e1699f (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b410a9aa-2014-4c25-8a54-2987477650e3 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bdd41c3a-c537-02f3-e053-2995a90a8929 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6560584-e39f-47b3-84db-95da1f90fd40 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:196ef773-8a2a-4ef7-a403-2341f94f4d98 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:30d15f4b-a0ee-4841-ace3-dcaf52016953 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca1c3b54-15a1-4252-938a-0d90f3bec4c5 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2e4298cf-02e9-49c7-9803-887161e1989a (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:05feb0a1-8a0c-4d8a-9b86-5e700ea6fd64 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:78341a0a-1274-417e-ae69-e133ee0480f9 (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0bef7cf2-012b-4804-ac93-0a8b333035db (opens source in a new tab)

        Felodipine label

        Version not recorded · Effective date not recorded

        The systemic plasma clearance of felodipine in young healthy subjects is about 0.8 L/min, and the apparent volume of distribution is about 10 L/kg.

Access

Query or download the projection

View this filtered page as JSONDownload up to 200 filtered CSV rows
GET /api/datasets/source-consensus?limit=10&offset=580

Allowed query parameters

q
Case-insensitive text search over the public fields named for this dataset.
state
Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
field
Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
limit / offset
Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.

Reuse and corrections

Keep the boundary attached

CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.

Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.

Read the correction policy